GlassScriptPhysician profile
Robert M Macmillan
NPI 1699736462
$2,112.09
in general payments reported to CMS, 2019-2025
21 companies · $250 in 2025
The $250 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2020: $196 · 2021: $382 · 2022: $368 · 2023: $560 · 2024: $187 · 2025: $250.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $997.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $997.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $374.43 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $331.09 | 2020-2023 | Farxiga, Brilinta |
| Amgen INC. | $184.10 | 2019-2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $176.71 | 2021-2025 | Lifevest |
| Amarin Pharma, INC. | $168.12 | 2020-2023 | |
| Medtronic, INC. | $114.43 | 2022-2025 | Symplicity G3 |
| E.R. Squibb & Sons, L.L.C. | $113.72 | 2020-2023 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $104.89 | 2019-2025 | |
| Lantheus Medical Imaging, INC. | $70.57 | 2021-2024 | |
| Impulse Dynamics (USA) INC. | $67.78 | 2022 | |
| Kestra Medical Technology Services, INC. | $67.29 | 2025 | Assure Wcd |
| Boston Scientific Corporation | $64.86 | 2019-2023 | Ekosonic |
| Novo Nordisk INC | $63.44 | 2023-2024 | Wegovy, Rybelsus, Ozempic |
| Abbott Laboratories | $52.08 | 2019-2024 | Mitraclip |
| Merck Sharp & Dohme LLC | $42.58 | 2023-2025 | Verquvo |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lexicon Pharmaceuticals, INC. | $23.20 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $22.17 | 2021 | |
| Edwards Lifesciences Corporation | $20.09 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.53 | 2025 | Jardiance |
| Pfizer INC. | $17.42 | 2025 | |
| Arbor Pharmaceuticals, INC. | $15.59 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Macmillan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.